Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk for Recurrent Cardiovascular Events and Expected Risk Reduction With Optimal Treatment 1 Year After an Acute Coronary Syndrome.
Zafeiropoulos S, Farmakis I, Kartas A, Arvanitaki A, Pagiantza A, Boulmpou A, Tampaki A, Kosmidis D, Nevras V, Markidis E, Papadimitriou I, Arvanitakis K, Sianos G, Makedou K, Ziakas A, Tzikas A, Karvounis H, Giannakoulas G. Zafeiropoulos S, et al. Among authors: pagiantza a. Am J Cardiol. 2020 Oct 15;133:7-14. doi: 10.1016/j.amjcard.2020.07.046. Epub 2020 Jul 28. Am J Cardiol. 2020. PMID: 32828524
Low-density lipoprotein cholesterol target value attainment based on 2019 ESC/EAS guidelines and lipid-lowering therapy titration for patients with acute coronary syndrome.
Farmakis I, Zafeiropoulos S, Pagiantza A, Boulmpou A, Arvanitaki A, Tampaki A, Kosmidis D, Nevras V, Markidis E, Papadimitriou I, Karvounis H, Giannakoulas G. Farmakis I, et al. Among authors: pagiantza a. Eur J Prev Cardiol. 2020 Dec;27(19):2314-2317. doi: 10.1177/2047487319891780. Epub 2019 Dec 9. Eur J Prev Cardiol. 2020. PMID: 31818140 No abstract available.
Reinforcing adherence to lipid-lowering therapy after an acute coronary syndrome: A pragmatic randomized controlled trial.
Zafeiropoulos S, Farmakis I, Kartas A, Arvanitaki A, Pagiantza A, Boulmpou A, Tampaki A, Kosmidis D, Nevras V, Markidis E, Papadimitriou I, Vlachou A, Arvanitakis K, Miyara SJ, Ziakas A, Molmenti EP, Kassimis G, Zanos S, Karvounis H, Giannakoulas G. Zafeiropoulos S, et al. Among authors: pagiantza a. Atherosclerosis. 2021 Apr;323:37-43. doi: 10.1016/j.atherosclerosis.2021.03.013. Epub 2021 Mar 17. Atherosclerosis. 2021. PMID: 33780749 Clinical Trial.
Comparative efficacy and safety of oral P2Y12 inhibitors for patients with chronic kidney disease and acute coronary syndrome: a network meta-analysis.
Farmakis IT, Doundoulakis I, Zafeiropoulos S, Pagiantza A, Apostolidou-Kiouti F, Kourti O, Kassimis G, Haidich AB, Karvounis H, Giannakoulas G. Farmakis IT, et al. Among authors: pagiantza a. Hellenic J Cardiol. 2022 Jan-Feb;63:40-65. doi: 10.1016/j.hjc.2021.06.008. Epub 2021 Jul 16. Hellenic J Cardiol. 2022. PMID: 34274518 Free article.
Low Molecular Weight Heparin in Improving RAO After Transradial Coronary Catheterization: The LOW-RAO Randomized Study.
Didagelos M, Pagiantza A, Zegkos T, Zarra K, Angelopoulos V, Kouparanis A, Peteinidou E, Kassimis G, Karvounis H, Ziakas A. Didagelos M, et al. Among authors: pagiantza a. JACC Cardiovasc Interv. 2022 Aug 22;15(16):1686-1688. doi: 10.1016/j.jcin.2022.05.047. Epub 2022 Jul 27. JACC Cardiovasc Interv. 2022. PMID: 35981848 Free article. Clinical Trial. No abstract available.
11 results